Biotest AG/ DE0005227201 /
02.08.2019 0:00:00 | Изменение - | Объем сделки | Бид- | Предложение- | Рыночная капитализация | Дивидендная доходность | Коэффициент Цена/Доход |
---|---|---|---|---|---|---|---|
22.00EUR | - | 116 Оборот: - |
-Величина цены спроса: - | -Величина цены предложения: - | 1.61 млрдEUR | 0.10% | - |
GlobeNewswire
1:51
ROSEN, LEADING INVESTOR COUNSEL, Encourages Gritstone bio, Inc. Investors to Secure Counsel Before I...
GlobeNewswire
1:39
“LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in China
GlobeNewswire
1:31
PATH INVESTOR ALERT: Edelson Lechtzin LLP Urges UiPath, Inc. (NYSE: PATH) Shareholders to Consult Le...
GlobeNewswire
1:30
ROSEN, A LEADING LAW FIRM, Encourages Charge Enterprises, Inc. Investors to Secure Counsel Before Im...
GlobeNewswire
1:17
TMCF President and CEO Dr. Harry L. Williams has released the following statement on the FY25 House ...
GlobeNewswire
1:15
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Fastly, Inc. Investors to Secure Counsel Before Importan...
GlobeNewswire
1:10
Ensho Therapeutics Launches with Phase 2-Ready Oral α4β7 Inhibitor for Inflammatory Bowel Disease
GlobeNewswire
1:00
Worldwide License Agreement for EA1080, Oral Selective α4β7 Integrin Antagonist, Signed between EA P...
GlobeNewswire
0:30
Renalytix Submits Hearing Request to Nasdaq Hearings Panel in Regard to Staff Delisting Determinatio...
GlobeNewswire
0:29
Oxford Lane Capital Corp. Prices Public Offering of $100,000,000 8.75% Notes Due 2030
GlobeNewswire
0:06
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Enphase Energy, Inc. Investors to Secure Counsel B...
GlobeNewswire
27.06
Amesite Announces Collaboration with Professional College Counselors to Offer Amesite Explorer Semin...
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница